ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Charcoal

Also written as “AST-120”, “charcoal” and “Z7200 with oral activated charcoal”.

Its studies are mostly in Multiple Sclerosis · Renal Insufficiency, Chronic · Asthma · Pouchitis · Hepatic Encephalopathy, led by 2 companies.

Drug pageCharcoal: every studyAll 37 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 3, since May 1, 20069 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Keenova Therapeuticsits history only70 open or runningphase 3since May 1, 2006May 1, 2006none ahead
Zambon SpA20 open or runningphase 1since Sep 2, 2014Sep 2, 2014none ahead

Also a collaborator on its studies: Kureha, Kyntra Bio and Toray Industries.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Zambon SpA only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 2, 2014First study: phase 1 study in AsthmaFirst studyNCT02237508 · 90 enrolled · United Kingdom
  2. Dec 14, 2015Phase 1 study in AsthmaNCT02631941 · 91 enrolled · United Kingdom

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 Zambon SpA leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT02631941Asthma · United Kingdom1CompletedJul 201691
NCT02237508Asthma · United Kingdom1CompletedFeb 201590

How it is read

Names in the registry

  • “AST-120”, 10 entries
  • “charcoal”, 2 entries
  • “Z7200 with oral activated charcoal”, 2 entries
  • “Symbicort Turbohaler with oral activated charcoal”, 1 entry
  • “Activated Charcoal”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.